1. Home
  2. RVMD vs VOYA Comparison

RVMD vs VOYA Comparison

Compare RVMD & VOYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVMD
  • VOYA
  • Stock Information
  • Founded
  • RVMD 2014
  • VOYA 1975
  • Country
  • RVMD United States
  • VOYA United States
  • Employees
  • RVMD N/A
  • VOYA N/A
  • Industry
  • RVMD Biotechnology: Biological Products (No Diagnostic Substances)
  • VOYA Life Insurance
  • Sector
  • RVMD Health Care
  • VOYA Finance
  • Exchange
  • RVMD Nasdaq
  • VOYA Nasdaq
  • Market Cap
  • RVMD 7.5B
  • VOYA 7.0B
  • IPO Year
  • RVMD 2020
  • VOYA 2013
  • Fundamental
  • Price
  • RVMD $38.11
  • VOYA $72.76
  • Analyst Decision
  • RVMD Strong Buy
  • VOYA Buy
  • Analyst Count
  • RVMD 12
  • VOYA 13
  • Target Price
  • RVMD $68.67
  • VOYA $82.75
  • AVG Volume (30 Days)
  • RVMD 3.3M
  • VOYA 815.3K
  • Earning Date
  • RVMD 08-06-2025
  • VOYA 08-05-2025
  • Dividend Yield
  • RVMD N/A
  • VOYA 2.49%
  • EPS Growth
  • RVMD N/A
  • VOYA N/A
  • EPS
  • RVMD N/A
  • VOYA 5.32
  • Revenue
  • RVMD N/A
  • VOYA $7,968,000,000.00
  • Revenue This Year
  • RVMD N/A
  • VOYA N/A
  • Revenue Next Year
  • RVMD $241.39
  • VOYA $4.98
  • P/E Ratio
  • RVMD N/A
  • VOYA $13.57
  • Revenue Growth
  • RVMD N/A
  • VOYA 5.34
  • 52 Week Low
  • RVMD $29.17
  • VOYA $52.43
  • 52 Week High
  • RVMD $62.40
  • VOYA $84.30
  • Technical
  • Relative Strength Index (RSI)
  • RVMD 47.77
  • VOYA 63.46
  • Support Level
  • RVMD $36.37
  • VOYA $71.87
  • Resistance Level
  • RVMD $38.97
  • VOYA $73.88
  • Average True Range (ATR)
  • RVMD 1.50
  • VOYA 1.34
  • MACD
  • RVMD 0.02
  • VOYA 0.16
  • Stochastic Oscillator
  • RVMD 40.07
  • VOYA 78.73

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.

About VOYA Voya Financial Inc.

Voya Financial Inc is a financial services company, which, through its subsidiaries, provides various investment, insurance, and retirement solutions to individual and institutional clients in the United States. Its products and services include tax savings plans, individual retirement accounts, group life insurance plans, and employee benefits products, among others. The company tailors each of its products to the needs of its customer base. It operates its business through three principal lines: Wealth Solutions, Investment Management, and Health Solutions The Wealth segment generates roughly half of the company's revenue.

Share on Social Networks: